KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Vir Biotechnology (VIR) Accumulated Depreciation & Amortization (2018 - 2025)

Vir Biotechnology's Accumulated Depreciation & Amortization history spans 8 years, with the latest figure at $11.7 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 19.77% year-over-year to $11.7 million; the TTM value through Dec 2025 reached $11.7 million, down 19.77%, while the annual FY2025 figure was $11.7 million, 19.77% down from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $11.7 million at Vir Biotechnology, up from $8.8 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $19.5 million in Q4 2023 and bottomed at $2.9 million in Q1 2025.
  • The 5-year median for Accumulated Depreciation & Amortization is $8.8 million (2024), against an average of $9.2 million.
  • The largest YoY upside for Accumulated Depreciation & Amortization was 260.37% in 2023 against a maximum downside of 64.55% in 2023.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $5.3 million in 2021, then increased by 28.51% to $6.8 million in 2022, then soared by 186.76% to $19.5 million in 2023, then decreased by 25.15% to $14.6 million in 2024, then fell by 19.77% to $11.7 million in 2025.
  • Per Business Quant, the three most recent readings for VIR's Accumulated Depreciation & Amortization are $11.7 million (Q4 2025), $8.8 million (Q3 2025), and $5.8 million (Q2 2025).